Andrew Arno - Apr 11, 2024 Form 4 Insider Report for Oncocyte Corp (OCX)

Role
Director
Signature
/s/ Andrew Arno
Stock symbol
OCX
Transactions as of
Apr 11, 2024
Transactions value $
$99,999
Form type
4
Date filed
4/15/2024, 06:02 AM
Previous filing
Jan 17, 2024
Next filing
May 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCX Common Stock, no par value Purchase $100K +33.9K +96.42% $2.95 69.1K Apr 11, 2024 Direct F1
holding OCX Common Stock, no par value 7.8K Apr 11, 2024 See footnote F2
holding OCX Common Stock, no par value 7.8K Apr 11, 2024 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares of the Issuer's common stock, no par value ("Common Stock"), purchased by the Reporting Person from the Issuer in a private offering.
F2 These shares of Common Stock are held by JBA Investments LLC ("JBA"). The Reporting Person is the Manager of JBA and, in such capacity, has the right to vote and dispose of securities held by JBA, including the shares of Common Stock reported here.
F3 These shares of Common Stock are held by MJA Investments LLC ("MJA"). The Reporting Person is the Manager of MJA and, in such capacity, has the right to vote and dispose of securities held by MJA, including the shares of Common Stock reported here.